Bunkerhill MAC vs Bunkerhill AVC

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS
by BunkerHill Health

AI Verdict

Bunkerhill MAC is an FDA-cleared AI algorithm specifically designed for the detection and quantification of mitral annular calcification on CT scans. Bunkerhill AVC, also FDA-cleared and from the same company, is part of a broader Carebricks generative AI platform that includes detection for aortic valve calcification, coronary artery calcification, bone density assessment, and also mitral annular calcification. While Bunkerhill MAC offers a focused solution, Bunkerhill AVC provides a more comprehensive suite of cardiovascular and bone density assessments within a unified AI platform.

Choose Bunkerhill MAC if…

Choose Bunkerhill MAC if your primary objective is the early identification and quantification of mitral annular calcification (MAC) from routine CT scans. This tool is ideal for integrating MAC detection into your cardiovascular risk stratification workflows, leveraging an FDA-cleared AI algorithm for automated analysis and care coordination.

View Bunkerhill MAC →

Choose Bunkerhill AVC if…

Choose Bunkerhill AVC if your focus is on the early detection and quantification of aortic valve calcification (AVC) using an FDA-cleared AI algorithm. This tool is best suited for health systems seeking a comprehensive generative AI platform like Carebricks that can opportunistically screen for multiple conditions, including AVC, coronary artery calcification, and bone density, from existing CT data.

View Bunkerhill AVC →

Bunkerhill MAC and Bunkerhill AVC are both FDA-cleared AI algorithms from Bunkerhill Health, designed to assist in cardiovascular risk identification using CT scans. The primary distinction lies in their specific focus: Bunkerhill MAC specializes in the detection and quantification of mitral annular calcification (MAC) on routine CT scans, aiming to identify patients at increased cardiovascular risk and facilitate care coordination within the Carebricks platform.

In contrast, Bunkerhill AVC, while also leveraging the Carebricks generative AI platform for clinical reasoning and action, is specifically tailored for the early detection and quantification of aortic valve calcification (AVC) from chest CTs. A key practical difference is that Bunkerhill AVC is presented as part of a broader suite of calcification detection tools within the Carebricks platform, which also includes capabilities for coronary artery calcification and opportunistic bone density assessment. Bunkerhill MAC, while integrated with Carebricks, is described with a singular focus on MAC.

A physician primarily concerned with identifying and managing mitral annular calcification should consider Bunkerhill MAC for its specialized capabilities in that area. However, a physician seeking a more comprehensive AI solution for various calcification assessments, including aortic valve, coronary artery, and potentially bone density, would find Bunkerhill AVC, as part of the broader Bunkerhill Health Carebricks platform, to be a more versatile option. Both tools integrate with existing EHRs and clinical systems, streamlining workflows for follow-up and care coordination.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill MAC Bunkerhill AVC
Pricing Contact for pricing Contact for pricing
Deployment Cloud-based, integrated with existing EHRs and clinical systems via Carebricks platform. Integrates with full Electronic Health Records (EHRs) and clinical archives within health systems.
FDA Status Yes AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill AVC

Tool B, representing the broader Carebricks platform, offers advanced features like customizable AI agents and natural language processing for patient record interaction. This suggests a more versatile and interactive user experience compared to Tool A, which is primarily described as a specific detection algorithm integrated with the platform.

Clinical Value

Bunkerhill AVC

Tool B provides significantly greater clinical value by offering automated detection and quantification for multiple conditions, including aortic valve calcification (AVC), coronary artery calcification (CAC), mitral annular calcification (MAC), and opportunistic bone density assessment (BMD). This comprehensive approach allows for broader opportunistic screening from a single CT scan, identifying more patients at risk for various conditions than Tool A's singular focus on MAC. Both are FDA-cleared, but Tool B's breadth is a clear advantage.

Pricing & Value

Bunkerhill AVC

While both tools require contacting the vendor for pricing, Tool B offers a substantially broader suite of features, encompassing multiple detection algorithms and a generative AI platform for clinical reasoning. This expanded functionality delivers significantly greater value for a potentially comparable or slightly higher investment compared to Tool A's single-purpose MAC detection.

Enterprise Readiness

Bunkerhill AVC

Tool B explicitly confirms HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical requirements for enterprise adoption in healthcare. Tool A only states these are 'likely, but not explicitly stated,' making Tool B's explicit confirmation a significant advantage for enterprise readiness, alongside its broader platform capabilities for diverse workflows.

Innovation

Bunkerhill AVC

Tool B demonstrates greater innovation by explicitly featuring a generative AI platform (Carebricks) for clinical reasoning and action, complete with customizable AI agents and natural language processing for patient record interaction. While Tool A integrates with Carebricks, Tool B represents the full innovative scope of the platform, extending beyond mere detection to more advanced AI applications.

Support & Docs

Tie

Neither the provided structured facts nor publicly available information from web searches offer specific details regarding the level of support or documentation available for either Tool A or Tool B. Without this information, it is not possible to differentiate between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill MAC Bunkerhill AVC
Name Bunkerhill MAC Bunkerhill AVC
Company Bunkerhill Health BunkerHill Health
Tagline Generative AI for clinical reasoning and action. Generative AI for clinical reasoning and action.
Description Focus Detects and quantifies mitral annular calcification (MAC) on routine CT scans. Early detection and quantification of aortic valve calcification from chest CTs.
Key Feature - MAC Detection AI-powered detection and quantification of Mitral Annular Calcification (MAC) Automated detection and quantification of mitral annular calcification (Bunkerhill MAC)
Key Feature - AVC Detection Not specified Automated detection and quantification of aortic valve calcification (Bunkerhill AVC)
Key Feature - CAC Detection Not specified Automated detection and quantification of coronary artery calcification (iCAC, Contrast CAC)
Key Feature - Bone Density Not specified Opportunistic bone density assessment (Bunkerhill BMD)

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill MAC and Bunkerhill AVC.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill MAC is an FDA-cleared AI algorithm specifically designed to detect and quantify mitral annular calcification (MAC) on routine, non-gated chest CT scans. In contrast, Bunkerhill AVC is an FDA-cleared algorithm that aids in the early detection and quantification of aortic valve calcification from non-gated, non-contrast chest CTs.
Bunkerhill MAC is an FDA-cleared AI algorithm that integrates with the Carebricks generative AI platform for clinical reasoning and action. The Carebricks platform, which includes Bunkerhill AVC, also lists automated detection and quantification of Bunkerhill MAC as one of its key features, indicating it is an offering within the broader platform.
The broader Bunkerhill Health platform (Carebricks), which includes Bunkerhill AVC, offers automated detection and quantification of coronary artery calcification (iCAC, Contrast CAC) and opportunistic bone density assessment (Bunkerhill BMD). It also provides customizable AI agents for diverse workflows and natural language processing for patient record interaction (Carebricks Chat).
Both Bunkerhill MAC and Bunkerhill AVC are designed for seamless integration with existing systems. Bunkerhill MAC is cloud-based and integrates with existing EHRs and clinical systems via the Carebricks platform, while Bunkerhill AVC integrates with full EHRs and clinical archives within health systems.
Bunkerhill MAC specifically analyzes routine, non-gated chest CT scans. Bunkerhill AVC detects and quantifies aortic valve calcification from non-gated, non-contrast chest CT images.
AI Tool Finder
AI-powered search. Results may not be comprehensive.